↓ Skip to main content

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Overview of attention for article published in Frontiers in Psychiatry, December 2020
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
20 Mendeley